NOV 02, 2019 BIOEQ IP AG AND COHERUS BIOSCIENCES, INC. LICENSE AND DEVELOPMENT AGREEMENTLicense and Development Agreement • February 27th, 2020 • Coherus BioSciences, Inc. • Biological products, (no disgnostic substances)
This LICENSE AND DEVELOPMENT AGREEMENT (this Agreement) is entered into effective as of Nov. 02, 2019 (the Effective Date) by and between Bioeq IP AG, having its place of business at [***] (Bioeq) and Coherus BioSciences, Inc., having its principal place of business at 333 Twin Dolphin Drive, Suite 600, Redwood City, CA, 94065, USA (Licensee).
LICENSE AGREEMENTLicense Agreement • February 27th, 2020 • Coherus BioSciences, Inc. • Biological products, (no disgnostic substances)
This LICENSE AGREEMENT (this “Agreement”) is entered into as of January 13th, 2020 (the “Effective Date”) by and between Innovent Biologics (Suzhou) Co., Ltd., a PRC corporation (“Innovent”) and Coherus BioSciences, Inc., a Delaware corporation (“Coherus”). Innovent and Coherus are each referred to herein by name or as a “Party” or, collectively, as the “Parties.”
